## Abstract Blood lymphocytes from tumor patients can specifically destroy cultivated neoplastic cells of the same histological origin as the tumors of the lymphocyte donors, irrespective of whether or not the donors have symptoms of growing tumor. The purpose of the present study was to investiga
Agglutination of murine tumor cells by sera from various cancer patients
✍ Scribed by Takashi Umeda; Takae Tanino; Michiko Saito; Kohji Egawa
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 552 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Sera from one patient with an ovarian carcinoma, one with sarcoma, one with a breast carcinoma, and four patients with melanoma were found to “potentiate” (i.e. increase) the cytotoxic effect of blood lymphocytes reactive to the respective type of tumor target cells. This effect was spe
## Abstract Lymph‐node cells of non‐sensitized mice were “armed” (i.e. made specifically cytotoxic) by exposure __in vivo__ to passively transferred sera from tumor‐bearing mice. Four hours after an intraperitoneal injection of antitumor serum, the lymph nodes were removed from recipient mice and t
## Abstract This study was aimed at characterizing the parameters which regulate human monocyte‐mediated cytotoxicity to tumor cells as well as characterizing the target cell specificity, kinetics, etc., of the cytotoxic mechanism. Normal human peripheral blood monocytes were cytotoxic to tumor cel
## Abstract Granulocytes of normal human donors were previously shown to have cytostatic activity __in vitro__ against a variety of tumor cell lines. In the present study, we have compared the levels of granulocyte‐mediated cytostatic activity in cancer patients and normal donors. In an initial stu